Ignite Creation Date:
2025-12-24 @ 11:52 PM
Ignite Modification Date:
2026-03-04 @ 10:41 AM
Study NCT ID:
NCT00560651
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-01-10
First Post:
2007-11-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
German Corneal Cross Linking Register
Sponsor:
Suphi Taneri
Organization:
Study Overview
Official Title:
German Corneal Cross Linking Register
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2025-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Corneal Cross Linking is new treatment modality for patients with keratoconus. A keratoconus is characterized by progressive bulging and thinning of the eye's cornea. Keratoconus is a potentially severely sight impairing condition that may necessitate corneal transplantation in the progressive state.
Corneal Cross Linking is designed to
* increase the cornea's mechanical stability
* to stop progression of bulging and thinning of the cornea
* to prevent the need for corneal transplantation
Corneal Cross Linking is performed by
1. Applying Riboflavin (Vitamin B2) eye drops every 2 minutes for 30 minutes to the cornea
2. Illuminating the cornea with UV-light
This register of Corneal Cross Linking procedures performed in Germany serves to
* gather long-term results
* detect rare complications and side-effects
* evaluate the efficacy in a large number of patients
Corneal Cross Linking is designed to
* increase the cornea's mechanical stability
* to stop progression of bulging and thinning of the cornea
* to prevent the need for corneal transplantation
Corneal Cross Linking is performed by
1. Applying Riboflavin (Vitamin B2) eye drops every 2 minutes for 30 minutes to the cornea
2. Illuminating the cornea with UV-light
This register of Corneal Cross Linking procedures performed in Germany serves to
* gather long-term results
* detect rare complications and side-effects
* evaluate the efficacy in a large number of patients
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: